IRADIMED CORPORATION IRMD
Set alert
80.65 USD +1.22 +1.54%
As of Nov 3, 3:02 PM ET
79.14 Day range 81.39
76.68 52-week range 105.15
- YTD
- -17.10%
- 1 year
- -4.12%
- Open
- 79.42
- Prev close
- 79.42
- Mkt cap
- 1.03B
- Vol
- 86.03K
- Avg vol
- 122.29K
- EPS
- 1.87
- P/E
- 43.17
- Div yield
- 0.93%
More statistics
- Low
- 79.14
- High
- 81.39
- Forward P/E
- 32.64
- Beta
- 0.94
- Short ratio
- 5.23
- Inst. own
- 62.70%
- Dividend
- 0.80
- Ex-div date
- Aug 13, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 85.66
- 200-d avg
- 92.54
- 1y target
- 118.00
5D chart
Events in this range
- Oct 30, 2026Earnings: 0.55; estimate 0.55; surprise 0%
Signals (96)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 3:45 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 3:35 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 3:30 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 3:20 PM | 23 hours ago |
| RSI: Oversold | Nov 2, 2:55 PM | 1 day ago |
| SMA: Bearish | Nov 2, 2:25 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:20 PM | 1 day ago |
| SMA: Bearish | Nov 2, 2:10 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:30 PM | 1 day ago |
| RSI: Overbought | Nov 2, 1:05 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 12:55 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:50 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:50 PM | 1 day ago |
| SMA: Bearish | Nov 2, 12:45 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:40 PM | 1 day ago |
| SMA: Bearish | Nov 2, 12:35 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:30 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 12:15 PM | 1 day ago |
Newest 20 of 96.
Financial health
Altman Z-Score
44.94 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 55.0×
FY 2016 5y median 36.2× FY 2025
P/S 14.8×
FY 2016 5y median 9.5× FY 2025
P/B 13.1×
FY 2016 5y median 8.0× FY 2025
P/FCF 72.0×
FY 2016 5y median 54.3× FY 2025
EV/EBITDA 40.2×
FY 2016 5y median 25.7× FY 2025
EV/Sales 14.2×
FY 2016 5y median 8.8× FY 2025
FCF Yield 1.4%
FY 2016 5y median 1.8% FY 2025
Profitability
Gross Margin 76.7%
FY 2016 5y median 76.7% FY 2025
Operating Margin 31.2%
FY 2016 5y median 30.0% FY 2025
Net Margin 26.8%
FY 2016 5y median 26.2% FY 2025
ROE 23.8%
FY 2016 5y median 22.2% FY 2025
ROIC 21.0%
FY 2016 5y median 19.3% FY 2025
ROA 20.7%
FY 2016 5y median 18.7% FY 2025
Growth (YoY)
Revenue 14.4%
FY 2016 FY 2025
Operating Income 19.0%
FY 2016 FY 2025
EPS (diluted) 16.7%
FY 2016 FY 2025
Free Cash Flow -2.5%
FY 2016 FY 2025
Financial Health
Current Ratio 8.0×
FY 2016 5y median 8.8× FY 2025
Quick Ratio 6.8×
FY 2016 5y median 7.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.7×
FY 2016 5y median -2.1× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 1.2%
FY 2016 5y median 2.0% FY 2025
Payout Ratio 66.9%
FY 2016 5y median 71.1% FY 2025
Annual · latest fiscal year ends 2025-12-31
